| The COVID-19 pandemic drove 45% of clinical trial sites to transition patients from in-person to remote visits using virtual trial solutions. 1 Disruptions preventing or limiting site access to patients, monitors, and CRAs are propelling long-lasting changes in the research industry, supported by the adoption of virtualization technologies. - Are you prepared to adopt a virtualization strategy?
- Can you respond to urgent remote requirements for patients and sites?
- Have you and your CRO evolved your technology approach to support fully remote study conduct?
- Will your strategy meet future standards for transforming trials?
Begin your three-minute assessment across 8 parameters today. To get additional information about the capabilities driving a successful response and approach to virtualization, download the eBook now. 1. Medidata: Clinical Trial Sites Share Frontline Insights into COVID-19 Impact | 
